Replies to post #42804 on Biotech Values

[DewDiligence]

>Is Iplex really not clinically superior to Increlex…<

Virtually everyone agrees that Iplex is the better drug, but it’s a matter of degree. Just how much better is it?

Here’s an excerpt from the recent feature article in the NY Times:

http://select.nytimes.com/search/restricted/article?res=F70A1FF93F5A0C748DDDAB0894DF404482

>>
Dr. Mitchell E. Geffner, a professor of pediatrics at the University of Southern California, said the advantages of Iplex were ‘more theoretical than real,’ and that it would probably not make a difference to patients if they had to switch to Tercica's drug.
<<

Evidently, this view was on target.